Performance of a Novel Concept for Internal Fixation of a Novel Peripheral Nerve Block Catheter

Trial statusNot yet recruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18+
SponsorNordsjaellands Hospital

About this trial

The goal of this study is to test a new type of nerve block catheter (a thin, flexible tube used to deliver pain medication). Researchers want to see if this new design stays in its original position better than current catheters and if it is easy for doctors to use.

The main questions the study aims to answer are:

Does the catheter tip stay in the correct position over time without moving or slipping (dislocation)?

Can the catheter be placed quickly and accurately using the new deployment system?

Researchers will test this prototype in a small group of participants. There is no comparison group for this initial study.

Participants will:

Have the catheter placed near a nerve in their leg a few days before a scheduled femoral (leg) amputation.

Undergo imaging or checks to see if the catheter has moved.

Have the catheter removed just before their scheduled surgery.

The catheter will be placed in an area of the leg that is already scheduled to be removed during surgery. This ensures that the study carries minimal risk to the participants.

Eligibility criteria

This trial does not accept healthy volunteers

Qualifiers

Adults aged 18 years or older

Scheduled for elective transfemoral amputation

Able and willing to provide informed consent

Disqualifiers

Known allergy to local anesthetics

Trial design

Design model

Sequential

Treatments tested in this trial

  • Novel Internal Fixation Nerve Block Catheter - Sciatic Nerve

    Device

    A peripheral nerve block catheter prototype featuring internal fixation to prevent dislocation and a rapid-deployment system. Catheters are placed under ultrasound guidance.

  • Novel Internal Fixation Nerve Block Catheter - Saphenous nerve

    Device

    Placement of the saphenous catheter is contingent upon an amputation line that allows for placement below the surgical site (distal to the cut).

Treatment groups

15 Participants
are divided into 2 treatment groups
Group A: Sciatic Nerve CatheterExperimental treatment 1 intervention
Group B: Saphenous Nerve CatheterExperimental treatment 1 intervention

Trial outcomes

Primary outcomes

1

Catheter Dislocation Distance

The absolute distance (in millimeters) between the position of the catheter delivery orifice at initial placement and its position just before removal. The position is verified by ultrasound imaging using hydrodissection with a local anesthetic bolus to identify the orifice.

Time frame
From initial placement (Day 0) to immediately prior to amputation surgery (typically 48-72 hours).

Secondary outcomes

1

Time on Task

Time required for catheter placement, measured from initiation of skin disinfection to final skin fixation using a stopwatch (seconds).

Time frame
At time of procedure (Day 0)
2

Primary Placement Success Rate

Proportion of successful primary catheter placements, defined as the accurate position of the delivery orifice verified by ultrasound

Time frame
At time of procedure (Day 0)
3

Catheter Clinical Performance (Sensory Block)

Sensitivity to a cooled vial (5°C) over the cutaneous innervation area (Tibial/Peroneal for sciatic; Saphenous for saphenous nerve).

Time frame
Day 0 (preprocedure and postprocedure), day 1, day 2, and day 3.
4

Catheter Retraction Force

The force required for catheter removal, measured with a digital handheld force transducer (Newtons).

Time frame
Day 3 (just before surgery)

Other outcomes

Sponsors and contacts

Click on the lead sponsor to view all of their trials.

Nordsjaellands Hospital

Lead sponsor

Hvidovre University Hospital

Collaborator

Nordstar Medical

Collaborator

This trial is not recruiting at the moment. You can still explore other options: